| Affiliation: | 1. Metabolic Disease and Obesity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia;2. Department of Medicine (Austin Hospital), The University of Melbourne, Melbourne, VIC, Australia;3. Department of Physiology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia;4. Max Plank Institute for Metabolism Research, Cologne, Germany;5. Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA;6. Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, CT, USA |
